tiprankstipranks
Advertisement
Advertisement

ADXN Stock Latest News

Addex Therapeutics announces publication of new ADX71743 preclinical research
The FlyAddex Therapeutics announces publication of new ADX71743 preclinical research
26d ago
ADXN
Addex Therapeutics announces GABAB PAM candidate data
PremiumThe Fly
Addex Therapeutics announces GABAB PAM candidate data
3M ago
ADXN
Addex Therapeutics says spin-out company to complete NTX-253 study in Q2
PremiumThe Fly
Addex Therapeutics says spin-out company to complete NTX-253 study in Q2
3M ago
ADXN
Addex Therapeutics Ltd – ADR trading resumes
PremiumThe Fly
Addex Therapeutics Ltd – ADR trading resumes
5M ago
ADXN
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
PremiumThe Fly
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
5M ago
ADXN
Addex publishes negative allosteric modulators data in Molecular Psychiatry
PremiumThe FlyAddex publishes negative allosteric modulators data in Molecular Psychiatry
6M ago
ADXN
Addex Therapeutics Ltd – ADR trading resumes
Premium
The Fly
Addex Therapeutics Ltd – ADR trading resumes
7M ago
ADXN
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
Premium
The Fly
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
7M ago
ADXN
Addex Therapeutics spin-out Neurosterix starts NTX-253 study
PremiumThe Fly
Addex Therapeutics spin-out Neurosterix starts NTX-253 study
7M ago
ADXN
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges
PremiumCompany Announcements
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges
8M ago
ADXN
Addex Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Addex Therapeutics Reports Q3 2025 Financial Results
8M ago
ADXN
Addex Therapeutics files to sell $150M in ordinary shares
PremiumThe Fly
Addex Therapeutics files to sell $150M in ordinary shares
9M ago
ADXN
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges
PremiumCompany AnnouncementsAddex Therapeutics Earnings Call: Strategic Gains Amid Challenges
10M ago
ADXN
Addex Therapeutics Reports Significant Loss Amid Financial Challenges
Premium
Company Announcements
Addex Therapeutics Reports Significant Loss Amid Financial Challenges
10M ago
ADXN
Addex Therapeutics Ltd – ADR trading resumes
Premium
The Fly
Addex Therapeutics Ltd – ADR trading resumes
1y ago
ADXN
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
PremiumThe Fly
Addex Therapeutics Ltd – ADR trading halted, volatility trading pause
1y ago
ADXN
Addex Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Addex Therapeutics Reports Q1 2025 Financial Results
1y ago
ADXN
Addex reports anti-tussive activity of GABAB positive allosteric modulator
PremiumThe Fly
Addex reports anti-tussive activity of GABAB positive allosteric modulator
1y ago
ADXN
Addex Therapeutics enters collaboration with Sinntaxis AB
PremiumThe Fly
Addex Therapeutics enters collaboration with Sinntaxis AB
1y ago
ADXN
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges
PremiumCompany AnnouncementsAddex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges
1y ago
ADXN
Addex Therapeutics Reports Strong 2024 Financial Turnaround
Premium
Company Announcements
Addex Therapeutics Reports Strong 2024 Financial Turnaround
1y ago
ADXN
Addex Therapeutics regains rights to ADX71149
Premium
The Fly
Addex Therapeutics regains rights to ADX71149
1y ago
JNJ
ADXN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >